BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37496460)

  • 1. Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Borella F; Bertero L; Valabrega G; Fucina S; Cassoni P; Benedetto C
    Int J Gynaecol Obstet; 2024 Jan; 164(1):262-269. PubMed ID: 37496460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer.
    Bizzarri N; D'Indinosante M; Marchetti C; Tudisco R; Turchiano F; Scambia G; Fagotti A
    Int J Clin Oncol; 2023 Feb; 28(2):314-320. PubMed ID: 36417028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis.
    Ceran MU; Tasdemir U; Colak E; Güngör T
    J Ovarian Res; 2019 Feb; 12(1):16. PubMed ID: 30744662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.
    Zhang WW; Liu KJ; Hu GL; Liang WJ
    Tumour Biol; 2015 Nov; 36(11):8831-7. PubMed ID: 26063409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer.
    Zhou M; Li L; Wang X; Wang C; Wang D
    Cell Physiol Biochem; 2018; 46(1):178-186. PubMed ID: 29587273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.
    Duan X; Yang B; Zhao C; Tie B; Cao L; Gao Y
    BMC Cancer; 2023 May; 23(1):432. PubMed ID: 37173662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer.
    Song Q; Xu SX; Wu JZ; Ling L; Wang S; Shu XH; Ying DN; Pei WW; Wu YC; Sun SF; Zhang YN; Zhou SH; Shao ZY
    Front Immunol; 2023; 14():1177403. PubMed ID: 37457691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma.
    Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J
    J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of pre-operative systemic immune-inflammation index and platelet to lymphocyte ratio in peritoneal carcinomatosis of ovarian origin.
    Ramón-Rodríguez J; De-Armas-Conde N; Jaén-Torrejimeno I; Prada-Villaverde A; Rojas-Holguín A; López-Guerra D; Blanco-Fernández G
    Surg Oncol; 2022 Jun; 42():101750. PubMed ID: 35378377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
    Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
    Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery.
    Plaja A; Teruel I; Ochoa-de-Olza M; Cucurull M; Arroyo ÁJ; Pardo B; Ortiz I; Gil-Martin M; Piulats JM; Pla H; Fina C; Carbó A; Barretina-Ginesta MP; Martínez-Román S; Carballas E; González A; Esteve A; Romeo M
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
    Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
    Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies.
    Zhao Z; Zhao X; Lu J; Xue J; Liu P; Mao H
    Arch Gynecol Obstet; 2018 Apr; 297(4):849-857. PubMed ID: 29368160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer.
    Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY
    Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the prognosis of resected early-stage patients with non-small cell lung cancer: A meta-analysis.
    Cao W; Yu H; Zhu S; Lei X; Li T; Ren F; Zhou N; Tang Q; Zu L; Xu S
    Cancer Med; 2023 Mar; 12(6):7065-7076. PubMed ID: 36480232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.